A Literature Review of Laboratory-Acquired Brucellosis

被引:113
|
作者
Traxler, Rita M. [1 ]
Lehman, Mark W. [1 ,2 ]
Bosserman, Elizabeth A. [1 ]
Guerra, Marta A. [1 ]
Smith, Theresa L. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
关键词
BRITISH CLINICAL LABORATORIES; OCCUPATIONAL HAZARD; MELITENSIS; INFECTIONS; OUTBREAK; DISEASE; TRANSMISSION; EXPOSURE; WORKERS; FEVER;
D O I
10.1128/JCM.00135-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Brucellosis is a bacterial zoonotic disease which has been associated with laboratory-acquired infections. No recent reviews have addressed the characteristics of laboratory-acquired brucellosis (LAB). English-language literature was reviewed to identify reports of laboratory exposures to Brucella spp. and LAB cases between 1982 and 2007. Evaluation of 28 case reports identified 167 potentially exposed laboratory workers, of whom 71 had LAB. Nine reports were identified that summarized an additional 186 cases of LAB. Only 18 (11%) exposures were due to laboratory accidents, 147 (88%) exposures were due to aerosolization of organisms during routine identification activities, and the circumstances of 2 (1%) exposures were unknown. Brucella melitensis was the causative agent in 80% (135/167) of the exposures. Workers with high-risk exposures were 9.3 times more likely to develop LAB than workers with low-risk exposures (95% confidence interval [CI], 3.0 to 38.6; P < 0.0001); they were also 0.009 times likelier to develop LAB if they took antimicrobial PEP than if they did not (95% CI, 0 to 0.042; P < 0.0001). The median incubation period in case and summary reports was 8 weeks (range 1 to 40 weeks). Antimicrobial PEP is effective in preventing LAB. The incubation period may be used to identify appropriate serological and symptom surveillance time frames for exposed laboratory workers.
引用
收藏
页码:3055 / 3062
页数:8
相关论文
共 50 条
  • [31] Survey of Laboratory-Acquired Infections
    Sulkin, S. Edward
    Pike, Robert M.
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1951, 41 (07): : 769 - 781
  • [32] LABORATORY-ACQUIRED GAMBIAN TRYPANOSOMIASIS
    RECEVEUR, MC
    LEBRAS, M
    VINCENDEAU, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03): : 209 - 210
  • [33] LABORATORY-ACQUIRED TYPHUS FEVERS
    WRIGHT, LJ
    BARKER, LF
    MICKENBERG, ID
    WOLFF, SM
    ANNALS OF INTERNAL MEDICINE, 1968, 69 (04) : 731 - +
  • [34] Laboratory-acquired vaccinia infection
    Wlodaver, CG
    Palumbo, GJ
    Waner, JL
    JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (03) : 167 - 170
  • [35] LABORATORY-ACQUIRED CAMPYLOBACTER ENTERITIS
    OATES, JD
    HODGIN, UG
    SOUTHERN MEDICAL JOURNAL, 1981, 74 (01) : 83 - 83
  • [36] SURVEY OF LABORATORY-ACQUIRED INFECTIONS
    SULKIN, SE
    PIKE, RM
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1951, 41 (07) : 769 - 781
  • [37] Laboratory-acquired serogroup a meningococcal meningitis
    Kessler, Alexander Tkeshelashvili
    Stephens, David S.
    Somani, Jyoti
    JOURNAL OF OCCUPATIONAL HEALTH, 2007, 49 (05) : 399 - 401
  • [38] CONTINUING IMPORTANCE OF LABORATORY-ACQUIRED INFECTIONS
    PIKE, RM
    SULKIN, SE
    SCHULZE, ML
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1965, 55 (02): : 190 - 199
  • [39] FIRST CASE OF LABORATORY-ACQUIRED HEPATITIS
    DONOVAN, JW
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1974, 68 (03) : 259 - 260
  • [40] LABORATORY-ACQUIRED HEPATITIS-B
    GRIST, NR
    LANCET, 1976, 1 (7952): : 205 - 205